April 23-26, 2018 | Fort Worth Convention Center | Fort Worth, TX | Exhibits April 24-26
Carnegie Mellon University
A graduate of Carnegie Mellon University, Andrew studied Biomedical Engineering as well as Materials Science, focusing on Tissue Engineering for regenerative medicine. As a researcher in Dr. Adam Feinberg’s Regenerative Biomaterials and Therapeutics Group, Andrew has spent the past two years researching ways to improve the resolution of 3D bioprinting. The goal of 3D bioprinting is to manufacture living tissues for drug and disease study with a long term objective of creating organs suitable for transplantation into patients.